Abstract | BACKGROUND: We clarified the correlation between brain damage, associated biomarkers and medication in psychiatric patients, because patients with schizophrenia have an increased risk of stroke. METHODS: The cross-sectional study was performed from January 2013 to December 2015. Study participants were 96 hospitalized patients (41 men and 55 women) in the Department of Psychiatry at Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan. Patients were classified into schizophrenia (n=70) and mood disorders (n=26) by psychiatric diagnoses with DSM-IV-TR criteria. RESULTS: CONCLUSION: Measurement of 3 biomarkers (CRP, PC-Acro and IL-6) are probably useful for judgement of severity of brain damage and effectiveness of medication in psychiatric patients.
|
Authors | Madoka Yoshida, Tetsuto Kanzaki, Mutsumi Mizoi, Mizuho Nakamura, Takeshi Uemura, Seisuke Mimori, Yoriyasu Uju, Keisuke Sekine, Yukihiro Ishii, Taro Yoshimi, Reiko Yasui, Asuka Yasukawa, Mamoru Sato, Seiko Okamoto, Tetsuya Hisaoka, Masafumi Miura, Shun Kusanishi, Kanako Murakami, Chieko Nakano, Yasuhiko Mizuta, Shunichi Mishima, Tatsuro Hayakawa, Kazumi Tsukada, Keiko Kashiwagi, Kazuei Igarashi |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 464
Pg. 50-56
(Jan 2017)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 27816667
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier B.V. All rights reserved. |
Chemical References |
- Antipsychotic Agents
- Biomarkers
|
Topics |
- Adult
- Antipsychotic Agents
(pharmacology, therapeutic use)
- Biomarkers
(blood)
- Brain Infarction
(complications)
- Brain Injuries
(complications)
- Cross-Sectional Studies
- Female
- Humans
- Inpatients
- Male
- Middle Aged
- Mood Disorders
(blood, complications, drug therapy)
- Schizophrenia
(blood, complications, drug therapy)
|